Lung Kee Group (SEHK:255) Loss In Latest Half Reinforces Concerns Over Earnings Weakness

Lung Kee Group Holdings (SEHK:255) has posted its FY 2025 first half results with revenue of HK$688.7 million and a basic EPS loss of HK$0.0056, while trailing twelve month figures show revenue of HK$1.3 billion and a basic EPS loss of HK$0.0358. Over recent periods, the company has seen revenue move from HK$785.2 million and HK$769.1 million in the first and second halves of FY 2024 to HK$688.7 million in the latest half, with EPS swinging between losses and modest profits across those intervals. For investors, the latest release points to pressured margins and ongoing earnings volatility. The key question is whether current profitability headwinds can be absorbed over time.

See our full analysis for Lung Kee Group Holdings.

With the headline numbers on the table, the next step is to see how this earnings profile lines up with the widely held narratives around Lung Kee Group Holdings and where the data starts to challenge those views.

Curious how numbers become stories that shape markets? Explore Community Narratives

TTM losses of HK$22.6 million keep profitability under pressure

• Over the trailing twelve months, Lung Kee Group Holdings recorded total revenue of HK$1,347.0 million and a net loss of HK$22.6 million, with basic EPS at a loss of HK$0.0358.
• Critics highlight that losses have worsened at around 63.8% per year over five years, and the latest trailing figures keep that bearish story in play, as:
• The shift from a net income of HK$6.7 million and EPS of HK$0.0106 in the earlier trailing window to a loss of HK$22.6 million and EPS loss of HK$0.0358 underlines how fragile profitability has been.
• Bears also point to the FY 2025 first half net loss of HK$3.6 million as another sign that, even with HK$688.7 million of revenue in that half, the business has not yet translated sales into consistent profits.

P/S of 0.7x and DCF fair value of HK$5.21 create a valuation gap

• The stock trades on a P/S of 0.7x, below the Hong Kong machinery industry average of 0.9x and peer average of 1.0x, while a DCF fair value of HK$5.21 is set against the current share price of HK$1.42.
• What stands out for bullish investors is that these valuation markers suggest the market is pricing in a lot of caution, because:
• The 0.7x P/S ratio sits below both industry and peer levels even though trailing twelve month revenue is HK$1,347.0 million. This gives bulls an argument that the business is being valued more cheaply per dollar of sales.
• The share price of HK$1.42 is described as 72.7% below the DCF fair value of HK$5.21, so anyone leaning bullish will see a wide gap between what the cash flow model suggests and what the market is currently paying.

11.27% dividend faces pressure from weak earnings

• The company pays a reported dividend yield of 11.27%, yet this sits alongside a trailing twelve month net loss of HK$22.6 million and negative EPS of HK$0.0358, meaning the payout is not covered by earnings.
• Skeptics warn that this combination supports a bearish income story, because:
• A dividend of 11.27% against unprofitable trailing results suggests cash is leaving the business while profit margins remain negative. This raises doubts about how long such a payout can be maintained without stronger earnings.
• The pattern of losses, including the HK$3.6 million loss in the first half of FY 2025 and multi year loss growth of about 63.8% per year, sits awkwardly next to such a high yield and can make income focused investors question the durability of that return.

To see how other investors weigh this mix of losses, a low P/S ratio, and a high dividend yield, and how that shapes the full story for Lung Kee Group Holdings, check out the 📊 Read the what the Community is saying about Lung Kee Group Holdings.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Lung Kee Group Holdings's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

Given the mix of pressure points and potential upsides in this story, it makes sense to review the numbers yourself and form your own view promptly, starting with the 1 key reward and 2 important warning signs.

See What Else Is Out There

With TTM losses of HK$22.6 million, volatile EPS and an 11.27% dividend not covered by earnings, Lung Kee Group Holdings currently carries meaningful risk signals.

If you want ideas that put more emphasis on resilience and downside protection, it is worth checking companies in the 284 resilient stocks with low risk scores that aim to limit these kinds of shocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com